课题基金 / 基金详情

A novel approach to analyze the immunological responses in human colorectal carcinoma

A novel approach to analyze the immunological responses in human colorectal carcinoma
分析人类结直肠癌免疫反应的新方法
批准号:
13671275
负责人:
MIZOI Takayuki
金额:
$2.62万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

MIZOI Takayuki的其他基金

相似基金

相关文献

中文摘要
翻译
1:大肠癌组织巨噬细胞、树突状细胞和淋巴细胞的流式细胞分析(1)我们通过酶切和Ficoll-Paque分离从大肠癌肿瘤和正常大肠癌组织中分离出单个核细胞。(2)流式细胞术分析显示CRC浸润缘的cd14阳性巨噬细胞多于正常粘膜组织。(3)与外周血淋巴细胞(PBL)相比,来自结直肠癌的T细胞以cd4为主,其中90%以上为记忆T淋巴细胞。(4)与PBL相比,结直肠癌中分离的T细胞以th1为主,且ⅰ型趋化因子CXCR3和CCR5阳性。(5)混合淋巴细胞反应实验表明,位于CRC的cd14阳性巨噬细胞具有刺激T细胞反应的能力。2:免疫组化分析(1)肿瘤单个核细胞表面抗原的免疫组化表达与流式细胞分析数据一致。(2) CRC浸润缘巨噬细胞Fas配体(FasL)阳性。fasl阳性巨噬细胞周围凋亡癌细胞的数量与fasl阳性巨噬细胞的数量相关。(3) CD4+ T细胞和CD8+ T细胞CXCR3和CCR5阳性。CD8+ T淋巴细胞表达RANITES,癌细胞和巨噬细胞表达IP- 10。
英文摘要
1: Flowcytometric analyses of macrophages, dendritic cells, and lymphocytes isolated from colorectal cancer(CRC) tissue(1) We isolated mononuclear cells from colorectal tumors and normal colorectal tissues by enzymatic digestion and Ficoll-Paque separation.(2) Flowcytometric analyses showed more CD14-positive macrophages in the invasive margin of CRC than in normal mucosal fissue.(3) T cells derived from CRC were CD4-dominant compared to peripheral blood lymphocytes (PBL) and more than 90 % of those were memory T lymphocytes.(4) The T cells isolated from CRC were Th 1-dominant compared to PBL and positive for type l chemokines, CXCR3 and CCR5.(5) A mixed lymphocyte reaction experiment demonstrated that CD14-positive macrophages located in CRC possessed the ability to stimulate T cell responses.2: lmmunohistochemlcal analyses(1) lmmunohistochemical expression of the surface antigens in mononuclear cells in tumor was consistent with the data of the flowcytometric analyses.(2) Macrophages along the invasive margin of CRC were Fas ligand (FasL)-positive. The number of apoptotic cancer cells around the FasL-positive macrophages was correlated with the number of the FasL-positive macrophages.(3) CD4+ T cells and CD8+ T cells were positive for CXCR3 and CCR5. CD8+ T lymphocytes expressed RANITES, and cancer cells and macrophages expressed IP- 10.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Sugita J et al.: "Close association between Fas ligand-positive tumor-associated macrophages and apoptotic cancer cells along invasive margin of colorectal carcinoma : a proposal on tumor-host interactions"Jpn. J. Cancer Res.. 93. 320-328 (2002)
Sugita J等人:“Fas配体阳性肿瘤相关巨噬细胞与结直肠癌浸润边缘的凋亡癌细胞之间的紧密关联:关于肿瘤-宿主相互作用的建议”Jpn。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sugita, J. et al.: "Close association between Fas 1 ligand(FasL ; CD95L)-positive tumor-associated macrophages and apoptotic cancer cells along invasive margin of colorectal carcinoma : A new paradigm of tumar-host interactions"Japanese Journal of Cancer
Sugita, J. 等人:“Fas 1 配体(FasL;CD95L)阳性肿瘤相关巨噬细胞与结直肠癌浸润边缘的凋亡癌细胞之间的紧密关联:肿瘤-宿主相互作用的新范例”日本癌症杂志
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Analysis of micro and molecular mechanism of lymphatic metastasis, and development of new strategy targeting for tumor lymphatic vessel
  • 批准号:
    15390370
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $9.15万
  • 财政年份:
    2003
  • 负责人:
    MIZOI Takayuki
  • 依托单位:
Inhibition of tumor growth, invasion, and metastasis by targeting CD44 molecule
  • 批准号:
    13557094
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $8.77万
  • 财政年份:
    2001
  • 负责人:
    MIZOI Takayuki
  • 依托单位:
消化器癌の増殖・転移に対する血管内皮前駆細胞の関与と遺伝子治療への応用
  • 批准号:
    11671204
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.43万
  • 财政年份:
    1999
  • 负责人:
    MIZOI Takayuki
  • 依托单位:
海外基金